IBJNews

Vanderbilt rejected by high court on Cialis patents

Back to TopCommentsE-mailPrintBookmark and Share

The U.S. Supreme Court refused to revive a bid by Vanderbilt University to have three of its scientists named as co-inventors on patents covering Eli Lilly and Co.'s Cialis impotence drug.

The justices on Monday left intact a ruling throwing out a lawsuit pressed by the Nashville, Tenn., university against Lilly’s Icos subsidiary. A federal appeals court, upholding a trial judge, concluded that the scientists didn’t play a role in creating the drug. Vanderbilt then asked the nation’s highest court to intervene.

Cialis in 2010 had third-quarter sales of $153.5 million in the United States and $406.5 million worldwide. Indianapolis-based Lilly acquired Icos and gained full control over Cialis in 2007.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT